Australia: Health Alert (Australia) - 28 January 2014



23 January 2014 - AstraZeneca AB v Alphapharm Pty Ltd [2014] FCA 9

AstraZeneca AB and AstraZeneca Pty Ltd, as prospective applicants, issued an originating application against Alphapharm, as prospective respondent, requesting pre-action discovery and inspection of documents, plus delivery of samples, relating to Alphapharm products.

AstraZeneca distributes a successful proton pump inhibitor that reduces production of stomach acid. It considered Alphapharm's products could infringe one or more patents it holds for that product.

AstraZeneca's application was allowed in part. Alphapharm complied with the orders but the documents provided did not satisfy AstraZeneca. AstraZeneca filed and served an Amended Originating Application, seeking further orders for discovery and inspection of specific documents and delivery of samples, pursuant to Rule 7.23 of the Federal Court Rules 2011 (Cth).

AstraZeneca relied specifically on Rule 7.23(1)(b), arguing it had insufficient information to decide whether to initiate proceedings to obtain relief for the threatened infringement of a particular patent, as its expert could not form a firm opinion regarding similarities between the products. Alphapharm maintained that this reference to "firm opinion" meant AstraZeneca was requesting more than just the "sufficient information" required for the purposes of the Rule.

Besanko J disagreed, concluding that the issue of what is "sufficient information" is very fact specific. He cited a Full Court decision explaining "that even where there is a reasonable cause to believe a person may have a right to relief ... that person may need information to know whether the cost and risk of litigation is worthwhile." He allowed the further discovery and inspection, but not delivery of samples.

16 January 2014 - Davie and Comcare, Re [2014] AATA 1

Compensation – Commonwealth employee – whether medications prescribed for compensable back injury caused sensorineural hearing loss and tinnitus – relevance of Statement of Principles in claims under Safety Rehabilitation and Compensation Act 1988 – comparative evidentiary value of various research studies and reports of general application and specifically focused expert medical evidence – burden and standard of proof – decision affirmed.


2 August 2013 - Psychology Board of Australia v Freeman [2013] QCAT 701

These proceedings stemmed from a complaint made that Dr Freeman's behaviour constituted unsatisfactory professional conduct. The complaint was made by a prisoner for whom Dr Freeman prepared a report concerning the complainant's application for parole. Dr Freeman diagnosed the complainant with borderline personality disorder, which was alleged to be an inappropriate diagnosis. It was also alleged that Dr Freeman reported on the complainant's psychopharmacological regime "inappropriately and beyond his qualifications." This decision concerned Dr Freeman's application to have Professor Smallbone's expert evidence excluded on the basis that he was "not an entirely independent witness, free from any actual or perceived bias or conflict of interest."

Professor Smallbone had previously provided reports to the Board in disciplinary proceedings against Dr Freeman following complaints made by two other prisoners. Dr Freeman questioned the appropriateness of calling a member of the profession who had previously formed an adverse view of his professional standards to express an opinion on those standards in another matter. He submitted that an objective onlooker would conclude Professor Smallbone was biased, and his evidence should therefore not be admitted.

It was agreed that expert evidence is admissible where the expert is qualified by training or experience to give expert evidence, and where there is no other rule disqualifying the evidence. As Dr Freeman did not challenge the relevance of Professor Smallbone's opinions or his expertise, the judge held the evidence admissible and dismissed the application.

United Kingdom

23 January 2014 - Jones v Portsmouth Hospitals NHS (National Health Service) Trust [2014] EWHC 42 (QB). Necrotising myositis is a rare condition with a high mortality rate which in July 2008 infected the upper right thigh of Mrs Karen Jones, the Claimant. It led to the progressive removal of all the muscles in her upper right thigh and the recommendation to amputate her right leg through the knee. The necrotising myositis was caused by Group A streptococcal bacteria, which probably started with a sore throat that the Claimant had had during the week leading up to her admission to Queen Alexandra Hospital in Portsmouth.

23 January 2014 - C v North Cumbria University Hospitals NHS Trust [2014] EWHC 61 (QB). This case concerns a narrow question: Was it negligent for a midwife to administer a second dose of a drug that induces labour?


Amendment statement of principles concerning posttraumatic stress disorder No. 19 of 2014.

National health (efficient funding of chemotherapy) special arrangement amendment instrument 2014 (No. 1) (No. PB 5 of 2014).

Aged Care Act 1997 - Determination under paragraph 44-19(1)(b) (ACA Ch. 3 No. 5/2007) Revocation Determination 2013.


Australia. Department of Health & Ageing

Private Health insurance (PHI) Circulars

8 January 2014 - PHI 01/14. Release of final data specifications for the hospital casemix protocol (HCP), private hospital data bureau (PHDB) and GT Dental 2013-14 data collections.

8 January 2014 - Private health insurance (data provision) rules 2013 & private health insurance (health insurance business) rules 2013.

9 January 2014 - New version (version of check-it 2 released.

17 January 2014 - Private hospital information.

20 January 2014 - Private health insurance (incentives) amendment rules 2013 (No. 1) and private health insurance (complying product) amendment rules 2013 (No. 5).

23 January 2014 - Hospital information - name change.

Australia. Health Practitioner Regulation Agency (AHPRA) and the boards

24 January 2014 - All AHPRA offices will be closed on Monday 27 January 2014 due to the Australia Day national public holiday.

22 January 2014 - The national psychology board has released January 2014 figures on area of practice endorsements. Read More.

Australia. National Health & Medical Research Council (NHMRC)

17 January 2014 - Minor amendments to the Australian immunisation handbook 10th edition. The NHMRC Chief Executive Officer has approved minor amendments to the Australian immunisation handbook 10th edition under section 14A of the National Health and Medical Research Council Act 1992. The Australian immunisation handbook provides clinical information for Australian immunisation providers on the safest and most effective use of vaccines, new vaccines and vaccine-preventable diseases in Australia. The minor amendments include text clarifications, updates, corrections and typographical errors.

Australia. Therapeutic Goods Administration

21 January 2014 - Liko overhead lifts ceiling-mounted rail systems. Consumers and health professionals are advised that Hill-Rom is undertaking a recall for product correction regarding ceiling-mounted rail systems.

20 January 2014 - Generic prescription medicines: Fact sheet on generic medicines for consumers.

17 January 2014 - Joint reclassification advice: summary technical reports as interim conformity assessment evidence for partial joint components. This information is intended for sponsors seeking to reclassify partial hip, knee and shoulder implants.

17 January 2014 - Reclassification of partial hip, knee and shoulder implants. Summary technical reports will be accepted as interim evidence to support applications for partial joint components.

17 January 2014 - Australian Public Assessment Reports for prescription medicines (AusPARs). Added Alogliptin as benzoate (Vipidia/Nesina).

Australian Institute of Health & Welfare

24 January 2014 - Medical workforce 2012 media release.

Australian Commission on Safety and Quality in Health Care

20 January 2014 - On the Radar – Issue 158 (103KB).

New South Wales (NSW). Ministry of Health

Media Releases

20 January 2014 - Record number of intern doctors in 2014.

21 January 2014 - Scholarships open for diploma of enrolled nursing.

22 January 2014 - NSW medical devices fund stage two preliminary applications open.

23 January 2014 - Project team appointed to plan next stage of St George hospital redevelopment.

Information Bulletins

17 January 2014 - Medical speciality coding in StaffLink.

Queensland. Department of Health

21 January 2014 - Queensland health repayments hit $3.5 million. In the past fortnight, another 1,000 Queensland health staff have committed to repaying an additional $1 million in overpayments caused by the former Labor Government's health payroll system failure.

21 January 2014 - More telehealth services for the south west. Queenslanders in the south west can look forward to more telehealth services.

Victoria. Department of Health

19 January 2014 - Victorians warned against deadly impact of tanning. A campaign urging Victorians to guard against the dangerous effects of excessive sun exposure will hit television screens again this summer.

Western Australia (WA). Department of Health

Operational Directives (OD)

23 January 2014 - OD 0486/14 WA health patient identification policy 2014 describes the content, colour and use of patient identification bands for all inpatients, emergency department and day procedure patients in WA hospitals.

New Zealand (NZ). Ministry of Health

17 January 2014 - Psychoactive substances manufacturing code now in force. Psychoactive substance manufacturers are now subject to the requirements of the new Code of Manufacturing Practice. Read more.

16 January 2014 - Gestational Trophoblastic Disease: New Zealand Gynaecologic Cancer Group guidelines. This guideline outlines the management of women after the diagnosis of molar pregnancy in NZ as agreed to by the NZ Gynaecological Cancer Group. Read more.

United Kingdom. Department of Health

23 January 2014 - Making mental health as important as physical health.

23 January 2014 - Treating patients as people.

23 January 2014 - NHS availability of erectile dysfunction drugs: proposed changes.

23 January 2014 - Consultation to improve regulation of health and social care providers.

21 January 2014 - Care needs: financial services industry to develop products to help people plan.

20 January 2014 - Making mental health matter more.

17 January 2014 - Progress on suicide prevention.

United States of America (US). Department of Health & Human Services (HHS)

23 January 2014 - US and UK working to strengthen use of health information technology for better patient care.

22 January 2014 - New committee to advise HHS on needs of children in disasters.

17 January 2014 - Surgeon General report says 5.6 million US children will die prematurely unless current smoking rates drop.

Australian Medical Association (AuMA)

22 January 2014 - AuMA to call for national action on alcohol – media conference in Sydney. Read more.

23 January 2014 - Time for a National Summit on alcohol misuse and harms - AuMA. The AuMA is today calling on the Federal Government to convene a National Summit to discuss and assess the evidence and develop effective national solutions to the epidemic of alcohol misuse and harms afflicting local communities right across the nation. Read more

British Medical Association (BMA)

20 January 2014 - BMA backs "self-care" campaign. A national "self-care" campaign, aimed at diverting pressures away from primary and secondary care, has been backed by the BMA.

20 January 2014 - Royal colleges urged to act on exam diversity findings. All medical royal colleges should monitor and evaluate the diversity of candidates taking their exams, a BMA review has urged.

17 January 2014 - Restraint of immigrant detainees alarms BMA. The BMA has expressed concern over the way frail and seriously ill immigrants at a UK detention centre were restrained during medical treatment.

17 January 2014 - Can a cash reward encourage breastfeeding? The overall health of society is determined by individual choice. Every day people choose to breastfeed, lose weight and give up smoking - but would more do so for a cash reward?

17 January 2014 - BMA secures "acting-up" allowance for SAS doctors. Specialty doctors will be recognised for acting up in the role of consultants, following successful BMA negotiations.

Canadian Medical Association (CMA)

23 January 2014 - New e-newsletter to feature customized content, far larger readership. Thanks to a relaunch of the CMA's e-newsletter, circulation is going to triple to 60,000 members in January, and for the first time the content they receive will be customized according to their membership in the student, resident or practising/retired member category.

20 January 2014 - Medical Doctors (MD) avoiding social media in droves: poll.

17 January 2014 - CMA acts on physician employment worries.

American Medical Association (AMA)

23 January 2014 - "A lot less of House, MD, and more of Car Talk:" A peek at medicine's future. As the nation considers ways to lower unsustainable health care costs and enhance the quality of patient care, renowned diagnostician Gurpreet Dhaliwal, MD, says physicians can learn valuable lessons from Click and Clack, longtime hosts of the popular Car Talk radio program.

23 January 2014 - Quality of clinical trial evidence varies greatly in Food and Drug Administration's (FDA)'s drug approval process. A new study in the Journal of the American Medical Association examined the US Food and Drug Administration's approval process for about two hundred new drugs over the past several years. The study found the quality of clinical trial evidence used by the FDA as the basis for recent approvals of novel therapeutic agents varied widely.

22 January 2014 - New faculty training program aims to transform medical education. A select group of faculty members of the Brody School of Medicine at East Carolina University are embarking on a year-long professional development program designed to develop skills for implementing new practice design and new curricula for today's environment of team based care.

21 January 2014 - How the AMA is easing physicians' regulatory loads. An AMA viewpoints post by AMA President Ardis Dee Hoven, MD. We physicians are part of so many powerful stories: Stories of injuries healed, cancers overcome and chronic conditions brought under control. But there's another story happening behind the scenes of clinical care that others need to hear.

© DLA Piper

This publication is intended as a general overview and discussion of the subjects dealt with. It is not intended to be, and should not used as, a substitute for taking legal advice in any specific situation. DLA Piper Australia will accept no responsibility for any actions taken or not taken on the basis of this publication.

DLA Piper Australia is part of DLA Piper, a global law firm, operating through various separate and distinct legal entities. For further information, please refer to

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:
  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.
  • Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.
    If you do not want us to provide your name and email address you may opt out by clicking here
    If you do not wish to receive any future announcements of products and services offered by Mondaq you may opt out by clicking here

    Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

    Use of

    You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


    Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

    The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


    Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

    • To allow you to personalize the Mondaq websites you are visiting.
    • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
    • To produce demographic feedback for our information providers who provide information free for your use.

    Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

    Information Collection and Use

    We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

    We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

    Mondaq News Alerts

    In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


    A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

    Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

    Log Files

    We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


    This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

    Surveys & Contests

    From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


    If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


    From time to time Mondaq may send you emails promoting Mondaq services including new services. You may opt out of receiving such emails by clicking below.

    *** If you do not wish to receive any future announcements of services offered by Mondaq you may opt out by clicking here .


    This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

    Correcting/Updating Personal Information

    If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

    Notification of Changes

    If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

    How to contact Mondaq

    You can contact us with comments or queries at

    If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.

    By clicking Register you state you have read and agree to our Terms and Conditions